Fundraising Fox

Adcendo

8 known investors

adcendo.com

Adcendo develops antibody-drug conjugates (ADCs) targeting cancers with high unmet medical need. The company engineers therapeutic medicines designed to deliver clinically differentiated outcomes for cancer patients.

BiotechMedical Devices

Investors · 8

In the news